Gustav Gaudernack

10.9k total citations · 1 hit paper
216 papers, 8.7k citations indexed

About

Gustav Gaudernack is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Gustav Gaudernack has authored 216 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Immunology, 80 papers in Oncology and 60 papers in Molecular Biology. Recurrent topics in Gustav Gaudernack's work include Immunotherapy and Immune Responses (111 papers), T-cell and B-cell Immunology (54 papers) and Immune Cell Function and Interaction (45 papers). Gustav Gaudernack is often cited by papers focused on Immunotherapy and Immune Responses (111 papers), T-cell and B-cell Immunology (54 papers) and Immune Cell Function and Interaction (45 papers). Gustav Gaudernack collaborates with scholars based in Norway, United Kingdom and United States. Gustav Gaudernack's co-authors include Erik Thorsby, Gunnar Kvalheim, Jarle Breivik, Jon Amund Eriksen, Jon Amund Kyte, Steinar Aamdal, Marianne Klemp, Stein Sæbøe‐Larssen, Gilla Kaplan and Ingvil Sæterdal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Gustav Gaudernack

213 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic vaccines for cancer: an overview of clinical trials

2014 614 citations Gustav Gaudernack et al. profile →

Peers

Gustav Gaudernack

IMMUN

ONCOL

GENET

PFM

Antonella Stoppacciaro Italy

Giulio C. Spagnoli Switzerland

Silvano Ferrini Italy

Paul M. Sondel United States

Christoph Huber Germany

Chiara Castelli Italy

James J. Mulé United States

Lori Fitz United States

Hiroshi Shiku Japan

Gerd Ritter United States

Antonella Stoppacciaro Italy

Gustav Gaudernack

4.7k ×1.0

IMMUN

2.9k ×0.7

ONCOL

4.3k ×1.4

970 ×1.3

GENET

552 ×0.8

PFM

Citations per year, relative to Gustav Gaudernack Gustav Gaudernack (= 1×) peers Antonella Stoppacciaro

Countries citing papers authored by Gustav Gaudernack

Since Specialization

Citations

This map shows the geographic impact of Gustav Gaudernack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustav Gaudernack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustav Gaudernack more than expected).

Fields of papers citing papers by Gustav Gaudernack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustav Gaudernack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustav Gaudernack. The network helps show where Gustav Gaudernack may publish in the future.

Co-authorship network of co-authors of Gustav Gaudernack

This figure shows the co-authorship network connecting the top 25 collaborators of Gustav Gaudernack. A scholar is included among the top collaborators of Gustav Gaudernack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustav Gaudernack. Gustav Gaudernack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nasi, Aikaterini, Stéphanie McArdle, Gustav Gaudernack, et al.. (2020). Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention. Toxicology Reports. 7. 768–771. 82 indexed citations

Mensali, Nadia, Amalie Grenov, Niladri Bhusan Pati, et al.. (2019). Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity. OncoImmunology. 8(3). 1558663–1558663. 22 indexed citations

Gaudernack, Gustav, et al.. (2017). Telomerase peptide vaccine combined with ipilimumab in metastatic melanoma: Reports from a phase I trial. Annals of Oncology. 28. v410–v410.

Zhao, Fang, Antje Sucker, Susanne Horn, et al.. (2016). Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency. Cancer Research. 76(15). 4347–4358. 57 indexed citations

Wang, Ping, Zhenhe Suo, Mengyu Wang, et al.. (2013). In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines. Experimental Hematology and Oncology. 2(1). 16–16. 8 indexed citations

Vik-Mo, Einar Osland, Marta Nyakas, Morten Carstens Moe, et al.. (2013). Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma. Cancer Immunology Immunotherapy. 62(9). 1499–1509. 257 indexed citations

Kyte, Jon Amund, Gustav Gaudernack, Svein Dueland, et al.. (2011). Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients. Clinical Cancer Research. 17(13). 4568–4580. 92 indexed citations

Brunsvig, Paal, Jon Amund Kyte, Christian Kersten, et al.. (2011). Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial. Clinical Cancer Research. 17(21). 6847–6857. 131 indexed citations

Strønen, Erlend, Gustav Gaudernack, Sébastien Wälchli, et al.. (2008). Dendritic Cells Engineered to Express Defined Allo‐HLA Peptide Complexes Induce Antigen‐specific Cytotoxic T Cells Efficiently Killing Tumour Cells. Scandinavian Journal of Immunology. 69(4). 319–328. 18 indexed citations

10.

Sæbøe‐Larssen, Stein, et al.. (2007). A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines. BMC Cancer. 7(1). 119–119. 47 indexed citations

11.

Gaudernack, Gustav. (2006). Prospects for vaccine therapy for pancreatic cancer. Best Practice & Research Clinical Gastroenterology. 20(2). 299–314. 11 indexed citations

12.

Gaudernack, Gustav, et al.. (2001). Mutation Analysis of <i>TP53</i> Exons 5–8 by Automated Constant Denaturant Capillary Electrophoresis. Tumor Biology. 22(5). 323–327. 13 indexed citations

13.

Fosså, Alexander, Reiner Siebert, Gunhild M. Mælandsmo, et al.. (2000). Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer. British Journal of Cancer. 83(6). 743–749. 28 indexed citations

14.

Thorsby, Erik, et al.. (1995). CD8+T cells from a patient with colon carcinoma, specific for a mutant p21-Ras-derived peptide (GLY13?ASP), are cytotoxic towards a carcinoma cell line harbouring the same mutation. Cancer Immunology Immunotherapy. 40(3). 165–172. 45 indexed citations

15.

Gedde‐Dahl, Tobias, et al.. (1993). Overlapping epitopes encompassing a point mutation (12 Gly → Arg) in p21 ras can be recognized by HLA‐DR, ‐DP and ‐DQ restricted T cells. European Journal of Immunology. 23(10). 2687–2691. 50 indexed citations

16.

Gjertsen, Henrik, Knut E. A. Lundin, Kjersti S. Rønningen, Gustav Gaudernack, & Erik Thorsby. (1991). T cells recognizing an HLA-DQ αß heterodimer encoded in Cis by the DR4DQw4 haplotype and in Trans by DR4DQw8/DRw8DQw4 heterozygous cells. Human Immunology. 30(3). 226–232. 15 indexed citations

17.

Gaudernack, Gustav & Knut E. A. Lundin. (1989). RAPID IMMUNOMAGNETIC PHENOTYPING OF CELLS. International Journal of Immunogenetics. 16(2). 169–175. 40 indexed citations

18.

Lundin, Knut E.A., Vidar Bosnes, & Gustav Gaudernack. (1989). Human T Lymphocyte Clones: Influence of Culture Conditions and Optimization of Proliferative Assays. Scandinavian Journal of Immunology. 30(1). 83–89. 4 indexed citations

19.

Lundin, Knut E.A., Gustav Gaudernack, Erik Qvigstad, Ludvig M. Sollid, & Erik Thorsby. (1988). T lymphocyte clones recognizing an HLA-DQw3.2-associated epitope involving residue 57 on the DQ β chain. Human Immunology. 22(4). 235–246. 23 indexed citations

20.

Leivestad, T., Gustav Gaudernack, & Elisabeth Qvigstad. (1986). Isolation of functionally active T-cell subsets by monoclonal antibodies conjugated to monodisperse magnetic microspheres (M-450). Transplantation Proceedings. 18(4). 731–732. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact